Global Anti-Infective Drugs Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Anti-Infective Drugs
- 1.1 Definition of Anti-Infective Drugs
- 1.2 Anti-Infective Drugs Segment by Type
- 1.2.1 Global Anti-Infective Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 OTC
- 1.2.3 Rx Drugs
- 1.3 Anti-Infective Drugs Segment by Applications
- 1.3.1 Global Anti-Infective Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Drugs Store
- 1.3.4 Other
- 1.4 Global Anti-Infective Drugs Overall Market
- 1.4.1 Global Anti-Infective Drugs Revenue (2014-2025)
- 1.4.2 Global Anti-Infective Drugs Production (2014-2025)
- 1.4.3 North America Anti-Infective Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Anti-Infective Drugs Status and Prospect (2014-2025)
- 1.4.5 China Anti-Infective Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Anti-Infective Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Anti-Infective Drugs Status and Prospect (2014-2025)
- 1.4.8 India Anti-Infective Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Anti-Infective Drugs
- 2.3 Manufacturing Process Analysis of Anti-Infective Drugs
- 2.4 Industry Chain Structure of Anti-Infective Drugs
3 Development and Manufacturing Plants Analysis of Anti-Infective Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Anti-Infective Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Anti-Infective Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Anti-Infective Drugs Production and Capacity Analysis
- 4.2 Anti-Infective Drugs Revenue Analysis
- 4.3 Anti-Infective Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Anti-Infective Drugs Regional Market Analysis
- 5.1 Anti-Infective Drugs Production by Regions
- 5.1.1 Global Anti-Infective Drugs Production by Regions
- 5.1.2 Global Anti-Infective Drugs Revenue by Regions
- 5.2 Anti-Infective Drugs Consumption by Regions
- 5.3 North America Anti-Infective Drugs Market Analysis
- 5.3.1 North America Anti-Infective Drugs Production
- 5.3.2 North America Anti-Infective Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Anti-Infective Drugs Import and Export
- 5.4 Europe Anti-Infective Drugs Market Analysis
- 5.4.1 Europe Anti-Infective Drugs Production
- 5.4.2 Europe Anti-Infective Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Anti-Infective Drugs Import and Export
- 5.5 China Anti-Infective Drugs Market Analysis
- 5.5.1 China Anti-Infective Drugs Production
- 5.5.2 China Anti-Infective Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Anti-Infective Drugs Import and Export
- 5.6 Japan Anti-Infective Drugs Market Analysis
- 5.6.1 Japan Anti-Infective Drugs Production
- 5.6.2 Japan Anti-Infective Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Anti-Infective Drugs Import and Export
- 5.7 Southeast Asia Anti-Infective Drugs Market Analysis
- 5.7.1 Southeast Asia Anti-Infective Drugs Production
- 5.7.2 Southeast Asia Anti-Infective Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Anti-Infective Drugs Import and Export
- 5.8 India Anti-Infective Drugs Market Analysis
- 5.8.1 India Anti-Infective Drugs Production
- 5.8.2 India Anti-Infective Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Anti-Infective Drugs Import and Export
6 Anti-Infective Drugs Segment Market Analysis (by Type)
- 6.1 Global Anti-Infective Drugs Production by Type
- 6.2 Global Anti-Infective Drugs Revenue by Type
- 6.3 Anti-Infective Drugs Price by Type
7 Anti-Infective Drugs Segment Market Analysis (by Application)
- 7.1 Global Anti-Infective Drugs Consumption by Application
- 7.2 Global Anti-Infective Drugs Consumption Market Share by Application (2014-2019)
8 Anti-Infective Drugs Major Manufacturers Analysis
- 8.1 GlaxoSmithKline
- 8.1.1 GlaxoSmithKline Anti-Infective Drugs Production Sites and Area Served
- 8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.1.3 GlaxoSmithKline Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Merck
- 8.2.1 Merck Anti-Infective Drugs Production Sites and Area Served
- 8.2.2 Merck Product Introduction, Application and Specification
- 8.2.3 Merck Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Pfizer
- 8.3.1 Pfizer Anti-Infective Drugs Production Sites and Area Served
- 8.3.2 Pfizer Product Introduction, Application and Specification
- 8.3.3 Pfizer Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis AG
- 8.4.1 Novartis AG Anti-Infective Drugs Production Sites and Area Served
- 8.4.2 Novartis AG Product Introduction, Application and Specification
- 8.4.3 Novartis AG Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Gilead Sciences
- 8.5.1 Gilead Sciences Anti-Infective Drugs Production Sites and Area Served
- 8.5.2 Gilead Sciences Product Introduction, Application and Specification
- 8.5.3 Gilead Sciences Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Abbott
- 8.6.1 Abbott Anti-Infective Drugs Production Sites and Area Served
- 8.6.2 Abbott Product Introduction, Application and Specification
- 8.6.3 Abbott Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Wyeth
- 8.7.1 Wyeth Anti-Infective Drugs Production Sites and Area Served
- 8.7.2 Wyeth Product Introduction, Application and Specification
- 8.7.3 Wyeth Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi-Aventis
- 8.8.1 Sanofi-Aventis Anti-Infective Drugs Production Sites and Area Served
- 8.8.2 Sanofi-Aventis Product Introduction, Application and Specification
- 8.8.3 Sanofi-Aventis Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Bristol-Myers Squibb
- 8.9.1 Bristol-Myers Squibb Anti-Infective Drugs Production Sites and Area Served
- 8.9.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.9.3 Bristol-Myers Squibb Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Johnson
- 8.10.1 Johnson Anti-Infective Drugs Production Sites and Area Served
- 8.10.2 Johnson Product Introduction, Application and Specification
- 8.10.3 Johnson Anti-Infective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Roche Pharma AG
- 8.12 Nanosphere
- 8.13 NanoViricides
- 8.14 Novabay Pharmaceuticals
- 8.15 Obetech
- 8.16 Optimer Pharmaceuticals
- 8.17 Basilea Pharmaceutica AG
- 8.18 Daiichi Sankyo
- 8.19 MerLion Pharma
- 8.20 Theravance
9 Development Trend of Analysis of Anti-Infective Drugs Market
- 9.1 Global Anti-Infective Drugs Market Trend Analysis
- 9.1.1 Global Anti-Infective Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Anti-Infective Drugs Regional Market Trend
- 9.2.1 North America Anti-Infective Drugs Forecast 2019-2025
- 9.2.2 Europe Anti-Infective Drugs Forecast 2019-2025
- 9.2.3 China Anti-Infective Drugs Forecast 2019-2025
- 9.2.4 Japan Anti-Infective Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Anti-Infective Drugs Forecast 2019-2025
- 9.2.6 India Anti-Infective Drugs Forecast 2019-2025
- 9.3 Anti-Infective Drugs Market Trend (Product Type)
- 9.4 Anti-Infective Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Anti-Infective Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The global Anti-Infective Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Infective Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Infective Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Infective Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Infective Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other